Does prostaglandin D2 hold the cure to male pattern baldness?

Experimental Dermatology

Volumn 23, Issue 4, 2014, Pages 224-227

  Nieves, Ashley ^a   Garza, Luis A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Alopecia; Arachidonic acid; Baldness; Hair; Lipids; Prostaglandins

Indexed keywords

ANDROGEN RECEPTOR; CYCLOOXYGENASE 2 INHIBITOR; GPR44 RECEPTOR; LIPOCALIN; MESSENGER RNA; PROSTAGLANDIN D 2 SYNTHASE; PROSTAGLANDIN D2; PROSTAGLANDIN D2 RECEPTOR; PROSTAGLANDIN RECEPTOR; TESTOSTERONE; UNCLASSIFIED DRUG; ISOMERASE; PROSTAGLANDIN R2 D-ISOMERASE;

ARTICLE; CORRELATION ANALYSIS; GENE OVEREXPRESSION; GENETIC ANALYSIS; HAIR FOLLICLE; HAIR GROWTH; HUMAN; KERATINOCYTE; MALE TYPE ALOPECIA; MASS SPECTROMETRY; NONHUMAN; SEBACEOUS GLAND; ALOPECIA; ANIMAL; MALE; METABOLISM;

ALOPECIA; ANIMALS; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; LIPOCALINS; MALE; PROSTAGLANDIN D2;

EID: 84896995060     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12348     Document Type: Article

References (60)

1. Paus R, Cotsarelis G. N Engl J Med 1999: 341: 491-497.
2. Price V H. N Engl J Med 1999: 341: 964-973.
3. Sawaya M E, Hordinsky M K. Adv Dermatol 1992: 7: 211-226; discussion 27.
4. Garza L A, Liu Y, Yang Z et al. Sci Transl Med 2012: 4 : 126ra34.
5. Garza L A, Yang C C, Zhao T et al. J Clin Invest 2011: 121: 613-622.
6. Inui S, Itami S. Exp Dermatol 2013: 22: 168-171.
7. Khidhir K G, Woodward D F, Farjo N P et al. FASEB J 2013: 27: 557-567.
8. Woodward D F, Tang E S, Attar M et al. Exp Dermatol 2013: 22: 145-148.
9. Johnstone M A, Albert D M. Surv Ophthalmol 2002: 47(Suppl 1): S185-S202.
10. Sasaki S, Hozumi Y, Kondo S. Exp Dermatol 2005: 14: 323-328.
11. Wolf R, Matz H, Zalish M et al. Dermatol Online J 2003: 9: 7.
12. Skolnik P, Eaglstein W H, Ziboh V A. Arch Dermatol 1977: 113: 939-941.
13. Menton D N. Am J Anat 1968: 122: 337-355.
14. Gates A H, Karasek M. Science 1965: 148: 1471-1473.
15. Zheng Y, Eilertsen K J, Ge L et al. Nat Genet 1999: 23: 268-270.
16. Sundberg J P, Boggess D, Sundberg B A et al. Am J Pathol 2000: 156: 2067-2075.
17. Nicolaou A. Prostaglandins Leukot Essent Fatty Acids 2013: 88: 131-138.
18. Urade Y, Watanabe K, Hayaishi O. J Lipid Mediat Cell Signal 1995: 12: 257-273.
19. Watanabe K. Prostaglandins Other Lipid Mediat 2002: 68-69: 401-407.
20. Colombe L, Vindrios A, Michelet J F et al. Exp Dermatol 2007: 16: 762-769.
21. Colombe L, Michelet J F, Bernard B A. Exp Dermatol 2008: 17: 63-72.
22. Alestas T, Ganceviciene R, Fimmel S et al. J Mol Med (Berl) 2006: 84: 75-87.
23. Michelet J F, Colombe L, Gautier B et al. Exp Dermatol 2008: 17: 821-828.
24. Fincham N, Camp R. Biochem J 1983: 212: 129-134.
25. Tai H H, Chi X, Tong M. Prostaglandins Other Lipid Mediat 2011: 96: 37-40.
26. Yan M, Rerko R M, Platzer P et al. Proc Natl Acad Sci USA 2004: 101: 17468-17473.
27. Ansari K M, Rundhaug J E, Fischer S M. Mol Cancer Res 2008: 6: 1003-1016.
28. Sung Y M, He G, Hwang D H et al. Oncogene 2006: 25: 5507-5516.
29. Sasaki T, Niizeki H, Shimizu A et al. J Dermatol Sci 2012: 68: 36-44.
30. Goodman L S, Gilman A, Hardman J G et al. Goodman & Gilman's the Pharmacological Basis of Therapeutics, 9th edn. New York, NY: McGraw-Hill, Health Professions Division, 1996: xxi, 1905 p., [1] p. folded plate p.
31. Eguchi N, Minami T, Shirafuji N et al. Proc Natl Acad Sci USA 1999: 96: 726-730.
32. Matsuoka T, Hirata M, Tanaka H et al. Science 2000: 287: 2013-2017.
33. Qu W M, Huang Z L, Xu X H et al. Proc Natl Acad Sci USA 2006: 103: 17949-17954.
34. Urade Y, Eguchi N. Prostaglandins Other Lipid Mediat 2002: 68-69: 375-382.
35. Bell-Parikh L C, Ide T, Lawson J A et al. J Clin Invest 2003: 112: 945-955.
36. Nelson A M, Loy D E, Lawson J A et al. J Invest Dermatol 2013: 133: 881-889.
37. Larson A R, Zhan Q, Johnson E et al. J Cutan Pathol 2013: Doi: 10.1111/cup.12286. [Epub ahead of print].
38. Muller-Decker K, Leder C, Neumann M et al. J Invest Dermatol 2003: 121: 661-668.
39. Bol D K, Rowley R B, Ho C P et al. Cancer Res 2002: 62: 2516-2521.
40. Geng L, Hanson W R, Malkinson F D. Int J Radiat Biol 1992: 61: 533-537.
41. Zhu H, Ma H, Ni H et al. Biol Reprod 2004: 70: 1088-1095.
42. O'Shaughnessy P J, Johnston H, Willerton L et al. J Cell Sci 2002: 115(Pt 17): 3491-3496.
43. Zhu H, Ma H, Ni H et al. Endocrine 2004: 24: 39-45.
44. Otsuki M, Gao H, Dahlman-Wright K et al. Mol Endocrinol 2003: 17: 1844-1855.
45. Amateau S K, McCarthy M M. Nat Neurosci 2004: 7: 643-650.
46. Choudhry R, Hodgins M B, Van der Kwast T H et al. J Endocrinol 1992: 133: 467-475.
47. Itami S, Kurata S, Sonoda T et al. Br J Dermatol 1995: 132: 527-532.
48. Pelletier G, Ren L. Histol Histopathol 2004: 19: 629-636.
49. Jave-Suarez L F, Langbein L, Winter H et al. J Invest Dermatol 2004: 122: 555-564.
50. Forman B M, Tontonoz P, Chen J et al. Cell 1995: 83: 803-812.
51. Kliewer S A, Lenhard J M, Willson T M et al. Cell 1995: 83: 813-819.
52. Trivedi N R, Cong Z, Nelson A M et al. J Invest Dermatol 2006: 126: 2002-2009.
53. Michelet J F, Commo S, Billoni N et al. J Invest Dermatol 1997: 108: 205-209.
54. Kvedar J C, Baden H P, Levine L. Biochem Pharmacol 1988: 37: 867-874.
55. Messenger A G, Rundegren J. Br J Dermatol 2004: 150: 186-194.
56. Heilmann S, Nyholt D R, Brockschmidt F F et al. Br J Dermatol 2013: 169: 222-224.
57. Millar S E. J Invest Dermatol 2002: 118: 216-225.
58. Chaurand P, Norris J L, Cornett D S et al. J Proteome Res 2006: 5: 2889-2900.
59. Lee B, Hirst J J, Walker D W. J Neurosci 2002: 22: 5679-5686.
60. Nicolaides N. Science 1974: 186: 19-26.